is a topic covered in the Davis's Drug Guide
To view the entire topic, please sign in or purchase a subscription.
Emergency Central is a collection of disease, drug, and test information including 5-Minute Emergency Medicine Consult, Davis’s Drug, McGraw-Hill Medical’s Diagnosaurus®, Pocket Guide to Diagnostic Tests, and MEDLINE Journals created for emergency medicine professionals. Explore these free sample topics:
-- The first section of this topic is shown below --
Used in the treatment of various solid tumors, lymphomas, and leukemias. Also used in some autoimmune disorders such as rheumatoid arthritis (cyclophosphamide, methotrexate). Often used in combinations to minimize individual toxicities and ↑ response. Chemotherapy may be combined with other treatment modalities such as surgery and radiation therapy. Dosages vary greatly, depending on extent of disease, other agents used, and patient's condition. Some agents (doxorubicin, irinotecan) are available in lipid-based formulations that have less toxicity with greater efficacy.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Quiring, Courtney, et al. "Antineoplastics." Davis's Drug Guide, 16th ed., F.A. Davis Company, 2019. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/50922/all/antineoplastics.
Quiring C, Sanoski CA, Vallerand AH. Antineoplastics. Davis's Drug Guide. 16th ed. F.A. Davis Company; 2019. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/50922/all/antineoplastics. Accessed October 17, 2019.
Quiring, C., Sanoski, C. A., & Vallerand, A. H. (2019). Antineoplastics. In Davis's Drug Guide. Available from https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/50922/all/antineoplastics
Quiring C, Sanoski CA, Vallerand AH. Antineoplastics [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2019. [cited 2019 October 17]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/50922/all/antineoplastics.
TY - ELEC
T1 - antineoplastics
ID - 50922
A1 - Quiring,Courtney,
AU - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/50922/all/antineoplastics
PB - F.A. Davis Company
ET - 16
DB - Emergency Central
DP - Unbound Medicine